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The apo- and metal-bound solution conformations of
synthetic conantokin-G (con-G, G1EggL5QgNQg10-
LIRgK15SN-CONH2, g 5 g-carboxyglutamic acid), an an-
tagonist of N-methyl-D-aspartate receptor-derived neu-
ronal ion channels, have been examined by one- and
two-dimensional 1H NMR at neutral pH. A complete
structure for the Mg21-loaded peptide was defined by
use of distance geometry calculations and was found to
exist as an a-helix that spans the entire peptide. The
a-helical nature of Mg21/con-G was also supported by
the small values (<5.5 Hz) of the 3JHNa coupling con-
stants measured for amino acid residues 3–5, 8, 9, and
11–16, and the small values (<4 ppb/K) of the tempera-
ture coefficients observed for the aNH protons of resi-
dues 5–17. This conformation contrasted with that ob-
tained for apo-con-G, which was nearly structureless in
solution. Docking of Mg21 into con-G was accomplished
by use of the genetic algorithm/molecular dynamics sim-
ulation method, employing the NMR-derived Mg21-
loaded structure for initial coordinates in the midpoint
calculations. For the 3 Mg21/con-G model, it was found
that binding of one Mg21 ion is stabilized by oxygen
atoms from three g-carboxylates of Gla3, Gla4, and Gla7;
another Mg21 is coordinated by two oxygen atoms, one
from each of the g-carboxylates of Gla7; and a third
metal ion through three donor oxygen atoms of g-car-
boxylates from Gla10 and Gla14. As shown from direct
metal binding measurements to mutant con-G peptides,
these latter two Gla residues probably stabilized the
tightest binding Mg21 ion. Circular dichroism studies of
these same peptide variants demonstrated that all Gla
residues contribute to the adoption of the Mg21-depend-
ent a-helical conformation in con-G.
The data obtained in this investigation provide a mo-
lecular basis for the large conformational alteration ob-
served in apo-con-G as a result of divalent cation bind-
ing and allow assessment of the roles of individual Gla
residues in defining certain of the structure-function
properties of con-G.
Conotoxins are small peptides present in the venoms of pred-
ator snails of the genus Conus. These pharmacologically active
materials are employed by the snails to paralyze their prey by
envenomation, thus enhancing their effectiveness as predators
of fish, mollusks, and polychaete worms (reviewed in Ref. 1). A
large number of these types of peptides are used by a variety of
species of these snails. Consequently, the structures and func-
tions of the peptides are diverse. The conotoxins are broadly
divided into three classes, those that function via effects on
acetylcholine receptors (a-conotoxins), muscle Na1 channels
(m-conotoxins), or voltage-sensitive Ca21-channels (v-conotox-
ins). In general, these small peptides are highly conformation-
ally constrained, in part due to disulfide bridges, viz., 2–4
disulfide loops over peptide stretches of 10–30 amino acids.
These types of constraints likely provide a smaller distribution
of possible conformations for these peptides, which in turn
might govern their tight receptor binding properties. Because
of their high functional selectivity, many different Conus pep-
tides are employed as probes of specific receptors (2).
Two Conus-derived venomous peptides of the conantokin
class have been well characterized. Referred to as con-G1 (3)
and con-T (4), they contain 17 and 21 amino acid residues,
respectively. These neuroactive peptides target for their func-
tions the ligand-gated Ca21/Na1 channels of the NMDA-R sub-
type, acting as noncompetitive inhibitors of ion flow through
the channels. On a molecular level, this property is based on
the noncompetitive inhibition by the conantokins of the posi-
tive allosteric effects of polyamines on this receptor (5). Struc-
turally, the conantokins lack disulfide bonds. However, these
peptides contain a very high relative amount of Gla, specifi-
cally, 5 mol/mol in con-G and 4 mol/mol in con-T. Because of
this feature, it is likely that some of the conformational stabil-
ity that is lacking due to the absence of disulfide bonds might
be accommodated by the divalent cation binding afforded these
peptides by the presence of Gla residues. This metal ion bind-
ing, the thermodynamic characteristics of which have been
described, might enhance the receptor binding properties of
these peptides by reducing the range of their possible confor-
mations (6). Therefore, recent activity in several laboratories
has centered on structures of the apo- and cation-loaded forms
of these peptides.
We have shown from CD measurements that apo-con-G is
relatively structureless, but its conformation is nearly entirely
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a-helical when the peptide is saturated with Ca21 and Mg21.
On the other hand, con-T contains a high relative amount of
a-helix in both states (6). This former conclusion is in basic
agreement with studies employing Fourier transformed-infra-
red spectroscopy (2), but it is at variance with NMR studies
that were designed to probe these same structures (7) and with
a study based on CD measurements (8), in which it was con-
cluded that significant amounts of helical conformations were
present in the metal-free form of con-G. Because of the possible
importance of the metal ion-induced conformational alteration
of con-G, we undertook a solution structural analysis of con-G
in its metal-free and Ca21- and Mg21-loaded forms, using one-
and two-dimensional 1H NMR. Although other NMR studies
have been published for the apo- and Ca21-dependent forms of
con-G (7, 9), as well as apo-con-T (9, 10), they have mainly
focused on backbone conformations. We recently performed
extensive 1H NMR studies on the solution conformation of
apo-con-T (11) and Ca21/con-T (12), allowing establishment of
both backbone and side-chain conformations. This same strat-
egy has now been applied to con-G to determine the backbone
and side-chain conformations of the metal-bound form. Results
of this structural analysis, as well as direct metal binding and
CD measurements of wild-type and mutant Con-G peptides,
are presented in the current report.
EXPERIMENTAL PROCEDURES
Peptide Synthesis—Con-G (G1EggL5QgNQg10LIRgK15SN-CONH2)
was synthesized by Fmoc chemistry on an Applied Biosystems (Foster
City, CA) model 433A peptide synthesizer using 5-(4-(9-fluorenylmethyl-
oxycarbonyl)-aminomethyl-3,5-dimethoxy-phenoxy) valeric acid resin
(PerSeptive Biosystems, Framingham, MA). The Na-Fmoc-(g,g9-di-O-
tBu)-L-Gla and Na-Fmoc-(g,g9-di-O-tBu)-D-Gla employed were chemi-
cally synthesized, as described previously (13). All other Na-Fmoc-L-
amino acids used in the synthesis of con-G were purchased from Sigma
or Nova Biochem (La Jolla, CA). The following side-chain protecting
groups were present on the amino acids: Arg(NG-2,2,5,7,8-pentamethyl-
chroman-6-sulfonyl), Asn(Ng-trityl), Gln(Nd-trityl), Glu(O-tBu), Lys(Ne-
t-butyloxycarbonyl), and Ser(O-tBu). The protocols employed for syn-
thesis, deprotection, and purification of the resulting con-G have been
described earlier (6). After deblocking, the peptide contained an ami-
dated carboxyl terminus, as is the case for naturally occurring con-G.
Sample Preparation—The samples for NMR measurements were
prepared by dissolving appropriate amounts of the purified peptide in
450 ml of a buffered solution containing 10 mM NaBO3, 100 mM NaCl,
pH 6.5. A volume of 50 ml of 2H2O was added to the peptide solutions to
provide the 2H lock signal. 4,4-Dimethyl-4-silapentane-1-sulfonate was
added as an internal reference. Peptide concentrations were approxi-
mately 1 mM for one-dimensional and 2 mM for two-dimensional NMR
experiments. Stock solutions of CaCl2 and MgCl2 at concentrations of
0.2 M were prepared in the same buffer used for the peptide samples. In
some experiments, CaCl2 and MgCl2 were titrated to the NMR samples
of the con-G peptide at concentrations up to 20-fold in excess of that of
the peptide.
NMR Measurements—All NMR experiments were carried out on a
Bruker AMX2–500 MHz and/or a DRX-500 MHz spectrometer at tem-
peratures of 5, 15, or 25 °C. The solvent H2O signal was suppressed by
use of the WATERGATE method for one-dimensional and most of the
two-dimensional NMR experiments, implemented through the 3-9-19
pulse train for selective inversion (14). The two-dimensional NMR ex-
periments included NOESY with water flip-back (15) and TOCSY (16,
17) using the TOWNY-16 spin-lock sequence (18). Water suppression in
the DQF-COSY (19) experiments was achieved by presaturation during
the preacquisition delay.
Two-dimensional NMR experiments were acquired using time pro-
portional phase incrementation along the t1 dimension for phase-sen-
sitive detection, with a relaxation delay of 1.5–2 s (20). Mixing times of
30–60 ms were used for the TOCSY experiments, and 150 ms and 250
ms for the NOESY spectra. Free induction decays were acquired with
2K complex data points for the TOCSY and NOESY data sets and with
4K complex data points for DQF-COSY experiments. A total of 400 t1
increments were collected for NOESY, 300–350 for TOCSY, and 512 for
DQF-COSY data sets. Sine modulation was used along the t1 dimen-
sion, with the initial t1 delays adjusted so that the zero and first-order
phase corrections along F1 were 90° and 0°, respectively (21).
The NMR data were processed using an in-house program, nmrDSP,
incorporating fast cosine and sine transformation, linear prediction,
and optimized baseline correction procedures. The free induction decay
matrices were multiplied by cosine-squared window functions in both
dimensions prior to Fourier transformation. The experimental data
were extended along the t1 dimension of the NOESY and TOCSY data
sets by linear prediction to 512 points and then zero-filled to 1024 before
the application of the window functions and sine transformation. The
matrices of the DQF-COSY spectra were 1K 3 1K real points for use in
resonance assignments and were expanded to 8K (F2) 3 1K (F1) for the
determination of coupling constants. The DQF-COSY spectra were
phased along the F2 dimension in both absorptive and dispersive
modes. The splittings of cross-peak extrema were measured in both
modes and were used to calculate the 3JHNa coupling constants cor-
rected for line width effects (22).
Proton Resonance Assignments—Residue-specific assignments of the
proton resonances were achieved by spin system identification using
DQF-COSY and TOCSY, followed by sequential assignments through
NOE connectivities (23). Despite a number of residues with similar spin
types, the dispersion of the amide proton resonances was sufficiently
large to allow the complete assignments of the proton resonances in the
absence and presence of metal ions. Gla residues were easily identified
in a TOCSY spectrum because their gCH proton resonances appear at
a lower frequency ('3 ppm). The side-chain amide protons of Asn and
Gln residues were assigned on the basis of the cross peaks in the amide
region of the TOCSY spectra and intraresidue NOESY cross peaks to
their bCH2 protons. The eNH proton of Arg
13 of con-G is well shifted
downfield in the presence of metal ions, and its assignment was based
on a strong TOCSY (and COSY) correlation to the dCH2 protons of Arg.
The guanidino protons of Arg13 in apo-con-G are very broad as a result
of solvent exchange and appear upfield of the backbone and side-chain
NH resonance envelope. In the presence of metal ions, these protons
also had intraresidue NOE connectivities to the eNH and dCH2 protons
of Arg13.
Structure Calculations—The intensities of the cross peaks in the
NOESY spectra of con-G were classified from the number of contours as
strong, medium, or weak and converted to distance upper bounds of 2.7,
3.7, and 5.0 Å, respectively. All side-chain/side-chain or side-chain/
main-chain medium-range (i, i 1 2 and i, i 1 4) constraints were set to
an upper bound of 5 Å and a lower bound of 2.0 Å. Starting structures
were generated by distance geometry using uniquely assigned NOE
constraints and with fixed bond lengths and bond angles provided in the
ECEPP/3 data base (24). Averaged distances between groups of protons
with resonance overlaps were required to satisfy both the upper and
lower bounds of the penalty function (25, 26). These initial structures
yielded information for assignment to specific proton pairs of some
overlapped NOEs. Optimization of the structures was carried out by
varying all dihedral angles except for the v angles governing the pla-
narity of the peptide bond (25–27). A set of low-energy structures was
selected for further calculations incorporating all NOE distance con-
straints in the distance geometry minimization. Visualization of the
structures was performed using the Sybyl software package (Tripos,
Inc.).
Docking of Mg21 in Con-G—Placement of the metal ions in con-G and
further energy minimization-based refinement of the metal-bound
structure were accomplished by the genetic algorithm-molecular dy-
namics simulation approach described previously (28). Briefly, the ini-
tial coordinates for Mg21/con-G used in the genetic algorithm midpoint
calculations were those determined by NMR in this study for the Mg21/
con-G complex. The initial positions of the Mg21 ions were determined
by searching through the O–O midpoints that were within 6 Å of each
other, using all oxygen atoms in the midpoint calculation. A total of 195
midpoints were found. The lowest Amber (29) energy structure, verified
also by a systematic search, was subjected to a Particle Mesh Ewald
molecular dynamics simulation (30). In this case, the peptide was
solvated in a 9.0-Å box, and H2O, Na
1, and Mg21 were energy-mini-
mized at constant volume. A Particle Mesh Ewald molecular dynamics
simulation was then performed on Na1, Mg21, and H2O for 100 ps,
followed by energy minimization. The side-chain residues, the ions, and
H2O were then subjected to another Particle Mesh Ewald molecular
dynamics simulation for 150 ps under conditions of fixed backbone,
followed by data collection over 300 ps.
Isothermal Calorimetry—The binding isotherms of Mg21 to con-G
and con-G mutants were determined by ITC measurements of the heat
changes accompanying titration of Mg21 into solutions of the relevant
con-G sample. The titrations were performed with a Microcal (North-
ampton, MA) OMEGA titration calorimeter at 25 °C in a buffer of 10
mM Na-Mes, 100 mM NaCl, pH 6.5. Peptide samples ranging in concen-
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trations from 0.23–1.0 mM (determined from quantitative amino acid
analysis) in a total volume of 1.4 ml were placed in the reaction cell.
After equilibration, an appropriate concentration of MgCl2 (typically
30–50 times higher than that of the peptide solution) in matching
buffer was delivered at discrete intervals, and the observed heat was
measured after each injection. The total observed heat was corrected for
the heat of dilution of the ligand by performing control titrations in the
absence of peptide. The resulting titration curves were deconvoluted
and inspected for the best-fit model using the ORIGIN for ITC software
package supplied by Microcal.
Circular Dichroism—CD spectra of the con-G peptides as a function
of metal ion concentration was monitored at 222 nm on an AVIV model
62DS spectrometer using a 1-cm path length cell. The relevant peptides
were dissolved in a solution of 10 mM NaBO3, 100 mM NaCl, pH 6.5, to
a final concentration of 35 mM. The a-helical content of the peptides at
various Mg21 concentrations were calculated as described previously
(31). The C50Mg-CD values (the concentration of Mg
21 required to
induce 50% of the alteration to the conformational change as deter-
mined by CD measurements) were determined by nonlinear least-
squares fitting of the data using a Michaelis-Menten-type equation.
RESULTS
Interactions of Con-G with Ca21 and Mg21 Ions—The nature
of the interaction of con-G with metal ions was assessed by use
of one-dimensional 1H NMR spectroscopy. Fig. 1 shows the
effects of additions of Ca21 and Mg21 on the spectrum of
apo-con-G. Here, it is seen that these cations influenced most of
the aNH proton resonances of con-G. Both shifts and broaden-
ing (Fig. 1B) of the resonance peaks were noted in the presence
of Ca21 (all proton resonance assignments for apo-con-G and
metal-loaded con-G are provided in Table S1a–c2). In the case
of Mg21, the proton signals are also shifted, but they remain
relatively sharp (Fig. 1C), therefore suggesting that Mg21 has
fully occupied its binding site(s) on con-G under the experimen-
tal conditions used (40 mM Mg21 and 2 mM con-G). The dra-
matic shifts observed in apo-con-G as a result of Ca21 and
Mg21 binding suggest that a conformational change in the
peptide accompanies cation/con-G interactions.
The well-resolved two-dimensional 1H NMR spectra of con-G
allowed chemical shifts to be assigned to all of the protons of
the peptide (Table S1a–c) and facilitated examination of the
residue-specific effects of metal binding in the one-dimensional
spectra (Fig. 1, A–C). In particular, the eNH resonance of Arg13
exhibits a very large downfield shift, from 7.5 to 8.1 ppm and to
8.7 ppm, as a consequence of Ca21 and Mg21 binding, respec-
tively. Also, the extremely broad guanidino resonance in the
apo-spectrum (Fig. 1A) narrows significantly in the metal-
bound spectra (Fig. 1, B and C). Clearly resolved are the bind-
ing-induced shifts of the amide proton resonances for the side-
chains of residues Asn8 and Gln9 and of the amide protons at
the carboxyl terminus. Also notable are the large up-field shifts
of the side-chain protons of residues that are incapable of metal
binding, viz., Leu5, Leu11, and Ile12 (Table S1a–c). These types
of alterations, which are present throughout the peptide, indi-
cate that global conformational reorientations occur in con-G
upon binding of metal ions to this peptide.
Conformational Changes in Con-G Induced by Ca21 and
Mg21 Binding—The secondary structure of con-G was investi-
gated by two-dimensional 1H NMR spectroscopy. All NMR ob-
servations on con-G indicate that this peptide has no defined
secondary structure in the absence of divalent cations. Initial
evidence in support of this point originates from the aCH
chemical shifts values, an approach commonly used to qualita-
tively identify secondary structural elements in peptides and
proteins (32). Because there are no reported random coil values
for the Gla residue, and because these chemical shifts would be
expected to be sequence-dependent in the random coil state, the
aCH proton chemical shifts of con-G determined in 6 M urea
were used as the reference random coil values. The fact that
four or more residues, without disruptions, do not experience
upfield or downfield shifts of 0.1 ppm or greater when com-
pared with the random coil values suggests that there is no
dominant secondary structure (Fig. 2). In addition, the temper-
ature coefficients of the backbone chemical shifts for apo-con-G
were determined through a series of TOCSY spectra acquired
at 5° intervals from 5 °C through 30 °C. A temperature coeffi-
cient in the range of 26 to 29 ppb/K was found for all backbone
aNH protons of apo-con-G. These values are consistent with
random coil conformation and suggest no preference for the
backbone hydrogen bonding that exists in a helical state.
Consistent with the chemical shift values, NOE patterns also
suggest that the peptide backbone of apo-con-G does not fold in
any preferred structural arrangement. Fig. 3A provides a sum-
mary of NOE values observed for con-G in the absence of
divalent metal ions. Except for intraresidue and sequential
NOEs, neither long-range nor medium-range NOE contacts
were observed at sample temperatures of 15 or 25 °C. Even at
a lowered temperature of 5 °C, there were only three very weak
2 Supplementary Tables S1a–c and S2 are available from the corre-
sponding author.
FIG. 1. Amide region of the proton
NMR spectra of con-G at pH 6.5 and
15 °C. The peptide concentration was ap-
proximately 2 mM. A, apo-con-G; B, con-G
in the presence of 40 mM Ca21; and C,
con-G in the presence of 40 mM Mg21. The
amide proton resonances of Glu2 and Gla3
were labeled with the one-letter code con-
vention (g 5 Gla) followed by the residue
number. The resonances for several side-
chain NH protons were also illustrated
with the one-letter code and the residue
number followed by the proton type. CA1
and CA2 represent the NH protons of the
carboxyl-terminal amide group. An impu-
rity signal is indicated by an asterisk. The
broad features in the Ca21/con-G spectra
remained the same with increased con-
centrations of Ca21, up to 100 mM.
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medium-range NOEs between the aNH protons of residues
Gln9 and Leu11 and residues Leu11 and Arg13 (i, i 1 2), and
between the aCH proton of Asn8 and the aNH proton of Leu11
(Fig. 3A). Additionally, 3JHNa coupling constants were found to
be approximately 7 Hz for all residues of apo-con-G (Table I),
again consistent with a peptide with no dominant conformation.
In contrast to apo-con-G, all NMR parameters of con-G in the
presence of Ca21 or Mg21 indicate that the peptide possesses a
substantial metal cation-induced a-helical structure. Large
negative values of deviations of the aCH proton chemical shifts
were seen for most residues in the presence of either Ca21 (Fig.
3B) or Mg21 (Fig. 3C). Of special note, .0.2-ppm shifts were
observed for seven amino acid residues in con-G in the presence
of Ca21 and for nine residues in the presence of Mg21. Positive
values for the aCH conformational shifts were detected for
some of the Gla residues, viz., Gla10 in the presence of Ca21,
and Gla3, Gla7, and Gla10 in the presence of Mg21. However,
because these positive values only occur for Gla residues, they
likely reflect direct metal ion binding effects, rather than the
conformations at these residues.
The NOE connectivities of Ca21-bound con-G are summa-
rized in Fig. 3B. Due to line broadening, the resonances could
not be assigned unambiguously at lower temperatures
(#15 °C). Thus, the NOEs shown in Fig. 3B were obtained at
25 °C. Even with sharper signals at the higher temperature,
some expected NOEs were not observed or could not be unam-
biguously assigned. Despite this, many NOEs characterizing
an a-helical structure were identified. For example, strong
sequential NOEs between the aNH protons were detected for
amino acid residues 3 to 9 and for residues 10 to 16. The
missing NOE contacts between the backbone amide protons of
residues 2 and 3, 9 and 10, and 16 and 17 are due to resonance
overlap in these cases. However, there were many (i, i 1 3)
NOE contacts between the aCH and the aNH protons of the
same residues in Ca21/con-G. Furthermore, five (i, i 1 3) NOE
connectivities between aCH and bCH protons were found, pro-
viding additional NOEs characteristic of an a-helical structure.
The NOE patterns of con-G in the presence of Mg21 are
illustrated in Fig. 3C. The observed NOEs fully characterize an
a-helical structure. Because of relatively sharp proton reso-
nances with Mg21, it was possible to assign many sequence-
specific NOEs that were not observable in the case of Ca21. The
a-helix appears to extend from the amino terminus to carboxyl
terminus of the peptide. This is supported by the expected (i, i
1 3) NOE connectivities, including aN(i, i 1 3) and ab(i, i 1 3).
In addition, NOE contacts between protons of aN(i, i 1 4) and
aN(i, i 1 2) were found for many pairs of residues. The fact that
the NOE intensities are much higher for aN(i, i 1 4) than for
aN(i, i 1 2) is an indication of that the metal ion-induced
conformation of con-G is mainly an a-helix.
Values of 3JHNa coupling constants also support the a-helical
conformation for Mg21-loaded con-G (Table I). Small values
(,5.5 Hz) of these coupling constants were detected for resi-
dues 3 to 5, 8, and 9 and for residues 11–16. Values of '6 Hz
were found for residues 2, 6, 7, and 17. Only one relatively large
value ('7 Hz) was observed for residue 10. Also, the tempera-
ture coefficients of amide proton chemical shifts for Mg21/con-G
were estimated from a series of TOCSY spectra accumulated in
a temperature range of 5–30 °C. Very small values (,4 ppb/K)
of the temperature coefficients were observed for the aNH
FIG. 2. Conformational shifts of the aCH protons for con-G in
the absence and presence of divalent cations. The open bars refer
to apo-con-G; the gray bars refer to apo-con-G in the presence of 40 mM
CaCl2; and the black bars refer to apo-con-G in the presence of 40 mM
MgCl2, at pH 6.5 and 15 °C. The chemical shift differences were calcu-
lated through subtraction of the corresponding shifts obtained for apo-
con-G in 6 M urea from the measured values.
FIG. 3. Summary of the sequential and medium-range NOE
connectivities observed for con-G at pH 6.5. A, apo-con-G; B, con-G
with Ca21; C, con-G with Mg21. The thickness of the bars provides a
qualitative measure of the strength of the NOE cross peaks. An asterisk
indicates that the assignment of the observed cross peak was ambigu-
ous due to resonance overlaps. The NOE summary for con-G with Ca21
was obtained at 25 °C because of broad proton signals at low tempera-
ture (Fig. 1B). The NOE connectivities for apo-con-G and con-G with
Mg21 were a combination of NOEs observed at different temperatures
(5, 15, and 25 °C). These NOEs observed for apo-con-G are very weak
and only appeared in the NOESY spectrum at a temperature of 5 °C.
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protons of residues 5–17, with the only exception being Asn8
('7 ppb/K). Such small values of the chemical shift tempera-
ture coefficients indicate that these backbone amide protons
are potential candidates for hydrogen bonding.
The Solution Structure of Con-G in Complex with Mg21
Ions—Because binding of Ca21 and Mg21 induces similar con-
formational changes in con-G, detailed structure investigations
were only performed for the Mg21/con-G complex, utilizing the
more extensive set of NMR parameters observed, with assign-
ments facilitated as a result of the sharp and well resolved
proton resonances of con-G in the presence of Mg21 ions. In
addition to an a-helical backbone, the conformations for the
side-chains of Mg21/con-G appear to be also well defined, espe-
cially those for residues 4–14, as indicated by the many back-
bone/side-chain and side-chain/side-chain NOE contacts among
these residues. For example, in addition to ab(i, i 1 3) NOE
contacts observed for most pairs of residues (Fig. 3C), back-
bone/side-chain NOE connectivities were found between the
proton pairs of Leu5-aCH and Asn8-dNH, Asn8-aCH and Leu11-
CH3, Gla
14-aNH and Gla10-gCH, Asn8-aNH and Leu5-CH3
(Fig. 4). Furthermore, both the aCH and aNH protons of Gln9
have NOE connectivities to the methyl protons of Ile12. The
aCH protons of Gla14, Lys15, and Asn17 were found to be in
contact with the protons of the carboxyl-terminal amide group.
Besides these backbone/side-chain NOE contacts, NOE connec-
tions between side-chain protons were detected for the proton
pairs of Gla3-gCH and Gla7-gCH, Asn8-dNH and Ile12-CH3,
Asn8-dNH and Gla4-bCH, and Gln9-eNH and Leu5-CH3.
The resonance characteristics of the side-chain NH protons
of Arg13 are particularly noteworthy. In apo-con-G, a normal
chemical shift was found for the eNH proton (Fig. 1A). When
con-G was loaded with Ca21 or Mg21, the resonance for this
proton was shifted .1 ppm downfield (Fig. 1, B and C). In
addition, the temperature coefficient for this proton is very
small (,4 ppb/K), indicating that it is a potential hydrogen
bonding candidate. Possible partners for this hydrogen bond
interaction could be the Gla10 backbone or the side-chain car-
bonyl groups of Gla10 and Gla14, because NOE connectivities
were observed between the eNH proton of Arg13 to the aCH
protons of Gln9 and Gla10 and to the gCH proton of Gla14 (Fig.
4). A weak NOE was also found between Arg13-hNH and Gla14-
gCH. Those observed NOEs place the side-chain of Arg13 in a
position in close contact with those of Gla10 and Gla14.
The Mg21-induced structure of con-G was calculated from
191 distance constraints, including 60 intraresidue, 49 sequen-
tial, and 82 of medium range (Table S2). One hundred initial
structures were generated by distance geometry calculations
using only backbone NOEs. Thirty of these structures with low
constraint violations were chosen for further structure optimi-
zation by combining backbone NOEs with additional side-
chain/side-chain NOE constraints. The initial structures also
allowed the assignment of some overlapped NOEs. Because the
exact position of the bound Mg21 ion was not known at this
stage, full energy minimization was not performed on the
NMR-based structural model because excluding bound cation
would have led to a poor definition of the metal-dependent
conformation. Fig. 5 illustrates 15 structures thus obtained
with their backbone atoms superimposed. This cluster of struc-
tures possess root mean square deviation values of 0.46 Å for
backbone atoms and 1.1 Å for all heavy atoms. The average
structure for Mg21/con-G is provided in Fig. 6. Here, it was
observed that the major subpopulation of structures of con-G in
complex with Mg21 is represented by an a-helix that spans the
entire length of the peptide.
FIG. 4. A portion of the two-dimen-
sional NOESY spectrum for con-G in
the presence of Mg21. Data were col-
lected at 15 °C with a mixing time of 250
ms. The sample conditions were 2 mM for
the peptide and 40 mM for MgCl2, pH 6.5,
in a buffer solution containing 10 mM so-
dium borate and 100 mM NaCl. Several
backbone and side-chain NH resonances
are illustrated along with long-range
NOE connectivities. The weak long-range
NOEs were also reproducibly observed in
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Docking of Mg21 in Con-G—The most probable locations of
the Mg21 ions in the con-G complex were identified using the
genetic algorithm-molecular dynamics simulation procedure
that has been successfully applied to even more complex struc-
tures of this type. For this procedure, a three-Mg21/con-G bind-
ing model was applied with two Na1 ions added to balance
charge. The three-step procedure (initial placement of the
Mg21 ions at each of the many possible oxygen-oxygen mid-
points, application of the genetic algorithm to locate the lowest
energy structure of all possible placements in which the ions
move, and finally, molecular dynamics on the solvated lowest
energy form in which the ions and side-chains have their ge-
ometries energy-optimized) resulted in a final coordination pat-
tern for which a Mg21 ion is coordinated to three oxygens from
Gla10 and Gla14, another Mg21 ion is coordinated to two oxy-
gens of Gla7, and the final ion is coordinated to oxygens from
Gla3, Gla4, and Gla7. The genetic algorithm procedure was
repeated several times with different genetic algorithm param-
eters, always with the same result. A two-Mg21 site model was
also subjected to the molecular dynamics minimization, but the
final model poorly predicted the Mg21 binding results of the
mutants. The average structure generated from the resulting
coordinates is shown in Fig. 7.
Binding of Mg21 to Con-G Mutants—To test the roles of
individual Gla residues in Mg21 binding using the models
proposed for the Mg21 con-G complex, binding isotherms were
determined for Mg21 in synthetic con-G-derived peptides
wherein each Gla residue was altered to Ala. The method
employed for these determinations was ITC, in which the heat
changes in con-G accompanying Mg21 binding were measured
and deconvoluted into thermodynamic characteristics of the
binding. A typical example of the binding isotherm obtained for
wild-type con-G is provided in Fig. 8. The data for all of the
mutants are of this same high quality. The resulting values of
the stoichiometry and Kd values that characterize Mg
21 bind-
ing to each of the mutant peptides generated in this report are
summarized in Table II. It is seen from this list that one tight
site and at least one weaker site, of Kd 10-fold greater than the
tight site, exist in the wild-type peptide. All mutants only
possess a single measurable Mg21 site. The tight site is not
present in the Gla4Ala, Gla10Ala, and Gla14Ala mutants, and
the weak site is not detectable in the remaining variants.
Con-G[D-Gla3,4,7,10,14], a peptide lacking secondary structure as
measured by CD3 was also examined by ITC. This con-G vari-
ant did not display an isotherm over the upper range of Mg21
concentrations employed in this study, suggesting that the
folded peptide, and not discrete Gla residues or dyads, is re-
sponsible for enforcing the metal binding loci. Although DH
values that characterize these interactions were also obtained,
we chose not to base any interpretations of the Mg21/con-G
binding characteristics on these values. This is because the
heats of reaction also likely contain contributions from heats
associated with the refolding of the peptides. Because there
was no way to separate these two phenomena at this stage, the
DH values associated strictly with cation binding could not be
3 T. Blandl and F. J. Castellino, unpublished results.
FIG. 5. Stereo view of a cluster of 15 converged structures for Mg21/con-G derived form distance geometry calculations. The
individual conformations were superimposed on backbone a-carbon atoms. The side-chains for Gla3, Gla4, Gla7, Gla10, and Gla14 are labeled and
are colored red. The clusters possess root mean square deviation values of 0.46 Å for backbone atoms and 1.1 Å for all heavy atoms.
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determined. However, this consideration does not affect deter-
mination of the Kd values by this method because saturable
titrations were observed, and only the incremental heat
changes accompanying Mg21 addition, not their absolute val-
ues, were required.
Mg21 induces a large conformational alteration in con-G, and
the functions of individual Gla residues in promoting the bind-
ing required for this change were examined by CD analysis of
the con-G mutants in the presence and absence of Mg21. For
this analysis, the effects of Mg21 on the molar ellipticities of the
peptides at 222 nm were determined, because a wavelength of
222 nm would effectively monitor alterations in the a-helical
conformations of the peptides. Examples of the titrations for
wild-type con-G and the mutant, con-G-Gla3Ala, are displayed
in Fig. 9. The relative propensities of the peptides to adopt the
Mg21-induced conformational changes are quantitatively com-
pared in Table II by determinations of the concentration of
Mg21 required to induce 50% of the alteration to the a-helical
conformation (C50Mg-CD). Here, it is seen that mutation of any
Gla residue diminishes the capacity of con-G to adopt its full
a-helical conformation. Interestingly, the Gla3Ala, Gla7Ala,
and Gla10Ala mutants require less Mg21 than the wild-type
peptide to induce the conformational change, whereas Gla4Ala
and Gla14Ala require greater levels of Mg21 for the change to
occur.
DISCUSSION
Conformational Stabilities of the Conantokin Peptides—De-
spite the relatively high sequence homology of con-T and con-G
(80% for Gla residues and 30% for all residues), they are struc-
turally diverse in their apo-forms. Con-T is nearly fully a-hel-
ical in the absence of divalent metal ions (11). Con-G exists
primarily as an unstructured peptide in aqueous solution with
some local structures, indicated by a few weak nonsequential
NOEs (Fig. 3A). However, these differences in the apo-struc-
tures can be explained by an analysis of the interactions of the
side-chains at the (i, i 1 3) and (i, i 1 4) positions. Con-T
contains many of the side-chain/side-chain interactions that
stabilize a-helical conformations in peptides, namely hydropho-
bic, electrostatic, charge-helix-dipole, end-capping, and hydro-
gen-bonding contacts (11). Con-G lacks appropriately spaced
hydrophobic residues and has only a few potential salt bridges
and ion pairs. Inspection of the central portion of the helices,
the region most important for structural stability, reveals that
con-T has an extensive (i, i 1 3) and (i, i 1 4) electrostatic
network, involving residues Gla3-Lys7-Gla10-Arg13-Gla14-Lys18
(11), whereas con-G has several potential electrostatic repul-
sions, viz., Gla3-Gla7-Gla10-Gla14 (Fig. 6). Although both pep-
tides have a potential Gln6-Gla10 hydrogen bond and an Arg13-
Gla14 ion pair, interactions that are believed to be important
for the stability of the apo-con-T a-helix, the presence of a Gla7
in con-G may be severely destabilizing. In addition, con-T has a
hydrophobic cluster (Tyr5-Met8-Leu9-Leu12) that likely contrib-
utes to the stability of the electrostatic interactions (11). The
corresponding residues in con-G are Leu5, Asn8, Gln9, and Ile12,
with two polar residues in positions 8 and 9 breaking the
hydrophobic cluster (Fig. 6). Thus, the drastic difference in
a-helicity between these peptides provides strong evidence that
FIG. 6. Comparison of the average structures of Ca21/con-T
and Mg21/con-G. The backbones of con-G (gold) and con-T (blue) in
these metal complexes were superimposed on the a-carbon atoms of
residues 1–17. Certain side-chains of interest are labeled. When two
such indications are made for overlapping residues, the first designa-
tion is for con-G and the second is for the corresponding residue in
con-T.
FIG. 7. The Mg21-loaded energy minimized structure of con-G.
A total of three Mg21 ions (black) were docked in this structure using
the genetic algorithm, beginning with the NMR-derived coordinates of
con-G loaded with Mg21. The structure was then refined by molecular
dynamics simulation. In this illustration, the side-chains (from the
b-carbons) of all amino acid residues of con-G are illustrated, and
certain residues are labeled. All side-chain carbon atoms are shown in
orange, nitrogens are blue, and oxygen atoms are red. A, space-filling
representation. B, the relationships between side-chain residues impli-
cated in binding to Mg21 and the Mg21 ions. The orientation is as in A.
The representations in A and B are not on the same scale.
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side-chain/side-chain interactions can contribute significantly
to a-helix stabilization, despite the unfavorable entropic con-
tributions consequent to immobilizing the conformation of the
side-chain atoms in the a-helix.
In contrast, a recent contribution has appeared in which it
was concluded from 1H NMR structural analysis that apo-
con-G contained a high degree of helical structure (7). This
observation is at variance with previous CD (6) and Fourier
transformed-infrared (2) studies, which showed that apo-con-G
was essentially structureless. It is possible that these differ-
ences arise from the use of a limited number of medium- to
long-range NOEs and the employment of 3JHNa coupling con-
straints as input for structural calculations.
Metal Ion Binding Sites in Con-G—Many cations, including
Ca21 and Mg21, induce a-helical conformations in con-G (6, 9)
and increase the existing a-helicity in con-T (6). The Gla resi-
dues, which are known to bind to Ca21 and other divalent and
trivalent cations when present in proteins, are the most likely
candidates for metal ion coordination in the conantokins. Ca21
titrations, employing a Ca21-selective electrode, revealed that
con-G possessed 2–3 metal binding sites (6). Similar values
were obtained for Mn21 by EPR titrations (33) and for Mg21 by
the ITC experiments described in the current report (Fig. 8 and
Table II). Despite the similarity between the number of Mg21
and Ca21 sites inferred from a variety of biophysical tech-
niques, there is a significant difference in the affinities of these
metals for con-G. The weak (Kd 5 2–3 mM) Ca
21 binding (6)
likely results in an exchange phenomenon that is slow on the
NMR time scale and that is manifest by excessive line broad-
ening (Fig. 1B). Furthermore, the broad aNH resonances in the
Ca21/con-G spectrum became sharper at a higher temperature
of 25 °C (data not shown), another indication of broadening by
conformational exchange among Ca21-free and Ca21-loaded
forms. It does not appear that aggregation of the peptide is an
adequate explanation of the observed resonance line widths,
because not all of the aNH protons of con-G exhibited spectral
broadening as a result of Ca21 binding (Fig. 1B). In addition,
previous data obtained with both con-G and con-T demon-
strated that Ca21-induced aggregation of these apo-peptides
did not occur under these conditions (6).
The impetus for solving the Mg21-loaded con-G peptide
structure stems from the obvious biological relevance of the
Mg21 ions in relation to the NMDA-R and from the availability
of high quality experimental data that allows for a detailed
conformational analysis that is not possible in the presence of
Ca21. The observation of a full peptide-spanning a-helix from
this current NMR study is a conclusion that contrasts some-
what with the structure recently reported for Ca21-induced
con-G conformation. In this latter case, some subpopulation of
310-helical structures was proposed (9). The most likely reason
for these differences is that many characteristic NOEs for an
a-helical structure were not observed in these studies due to
broad proton resonances of con-G in the presence of Ca21. In
contrast, the backbone of the Mg21-dependent con-G average
structure is clearly well-defined by the NOE-driven structural
analysis because many NOEs were observed among both the
backbone and the side-chain protons (Figs. 3C and 4).
Due to well-defined side-chains in the NMR-derived solution
structure of Mg21-loaded con-G, the location of metal binding
sites can be credibly proposed. The spatial proximity of Gla10
and Gla14 in the solution structure (Figs. 5 and 6) suggests that
they may constitute one of the metal binding locations. It is
interesting to note that the Gla10 and Gla14 are conserved in
con-T and con-G. A single strong metal binding site exists in
con-T, as reported previously (6), along with a possible weaker
site. This lone strong metal ion binding site in con-T is coordi-
nated by the side-chains of Gla10 and Gla14, as revealed from
molecular dynamics simulations and from analysis of variant
con-T-based peptides (12). The clustering of Gla3, Gla4, and
Gla7 in con-G suggests that metal ions may also bind at a site
involving these residues.
1H NMR chemical shifts can provide some evidence for which
residues are involved in binding to the metal ions. For example,
binding of divalent metal ions may induce chemical shift vari-
ations of the gCH protons of Gla residues. In fact, compared
FIG. 8. The binding of Mg21 to con-G. The effects of the addition of
Mg21 on the heat changes of con-G were determined by ITC. Top,
incremental heat changes accompanying titration of con-G with Mg21
at 25 °C. A sequence of 3-ml injections from a stock solution containing
40 mM MgCl2 was added to the sample cell containing 690 mM con-G.
The buffer was 10 mM Na-Mes, 100 mM NaCl, pH 6.5, at 25 °C. Each
injection took place over a 10-s time interval, with 2 min between
injections. The cell volume was 1.40 ml. Bottom, the heat changes per
mole of Mg21 injected are plotted against the molar ratio of Mg21 to
con-G. The line is the best-fit of the data to a binding isotherm charac-
terized by n1 5 1.0, Kd1 5 20 mM, DH1 5 23.18 kcal/mol; n2 5 0.97, Kd2
5 286 mM, DH1 5 24.69 kcal/mol.
TABLE II





con-G 2 (73) 120 0.97 20
1.02 286
Gla3Ala 5 (44) 58 1.08 34
Gla4Ala 0 (59) 240 0.69 186
Gla7Ala 5 (32) 38 0.84 17
Gla10Ala 7 (31) 100 1.04 111
Gla14Ala 11 (39) 430 0.95 544
a The initial (and final) a-helical content from analysis of the CD
changes.
b The total concentration of Mg21 required for 50% of the conforma-
tional change as determined from CD measurements.
c The stoichiometry (n) and dissociation constant (Kd) that character-
ize the binding of Mg21 to the indicated peptides as determined from
ITC measurements. The reported n and Kd values represent the aver-
age of two experiments and did not deviate by more than 15% between
experiments.
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with the Mg21-free form (Table S1a), large downfield shifts
(ranging from 0.4 to 0.6 ppm) were observed for the gCH
protons of Gla3, Gla7, Gla10, and Gla14 in the Mg21-loaded state
(Table S1c). These observations indicate that the environments
for these gCH protons are quite different between apo-con-G
and the Mg21/con-G complex. On the other hand, there is a
smaller change for the gCH proton of Gla4 upon metal biding,
suggesting that it is minimally involved in such binding, as was
the case for Ca21 binding to con-T (12). Furthermore, there are
large and positive deviations for the aCH chemical shifts of
Gla3, Gla7, and Gla10 (Fig. 2C). A downfield shift of aCH proton
resonances, relative to those for the random coil conformation,
is usually an indication of an extended conformational state.
However, these changes could be due to the local effects in-
duced by the bound cations because all other NMR parameters
indicate that a-helix disruption does not likely occur in the
Mg21/con-G complex. Because these types of experiments do
not localize the metal ion binding site any more exactly, we
undertook an additional modeling approach for this purpose.
Localizing the Mg21 Binding Sites in Con-G—For predic-
tions of the locations of Mg21 binding sites in con-G, the genetic
algorithm-molecular dynamics simulation methodology was
employed, because that approach has proved to accurately pre-
dict cation binding sites in even more complex peptides, such as
the Gla domain of coagulation fIX (28). To maximize its predic-
tive power, the peptide coordinates employed for initial calcu-
lations were those from the NMR-derived structure of the
Mg21/con-G complex. Although the direct Mg21 binding data
with wild-type con-G were more consistent with a two-site
versus a three-site cation:peptide model, the latter was chosen
for further elaboration because the NMR analysis of con-G and
the direct binding data with the mutant peptides were more
suggestive of this model.4 Specifically, the two site model elim-
inated Gla14 from coordination of Mg21, and this was inconsis-
tent with Mg21/mutant peptide binding data (Table II). Addi-
tionally, the NMR data show clear chemical shift changes of the
gCH proton of Gla14 upon addition of either Ca21 or Mg21
(Table S1a–c). Thus, we propose the model in Fig. 7 as one that
fits the majority of other experimental evidence. In this case,
one Mg21 ion is coordinated by g-carboxylate oxygen atoms of
Gla3, Gla4, and Gla7; another only by those of Gla7; and a third
by g-carboxylate oxygen atoms of Gla10 and Gla14. The loca-
tions of the Ca21 ions in con-T (12) and of the Mg21 ions in
con-G are somewhat different. Not insignificant in determining
this distribution is Gla7, a residue not present in con-T. This
side-chain provides a coordination site for a Mg21 ion that is
also shared by Gla3 and Gla4. In the case of con-T, wherein Gla4
does not appear to participate in metal binding, the side-chain
carbonyl oxygen at Gln6 serves as a donor residue for one Ca21
ion, along with the Gla3 g-carboxyl oxygen (33). Thus, it ap-
pears as though the presence of Gla7 has the effect of involving
Gla4 in cation binding in con-G. The other Ca21 ion bound to
con-T is coordinated by only the Gla10 and Gla14 side-chain
oxygen atoms (12). Similarly, the model of Mg21 binding to
con-G appears to allow one ion be coordinated by these same
side-chain atoms. Finally, if another weak Mg21 site exists in
con-G and, as discussed above, the direct binding data is am-
biguous in that regard, its donor oxygen atoms would originate
from each of the g-carboxylate oxygen atoms of Gla7. This
would be expected to be a very weak binding site, as suggested
from Ca21-selective electrode titrations of malonic acid which
yielded a Kd for Ca
21 of 4.5 mM.5
The a-Helical Structure as the Bioactive Conformation—
Ca21 and Mg21 play critical roles in NMDA-R function; Ca21 is
the cation transported through the open channel, and a Mg21
site on the receptor plays an important role as a voltage-de-
pendent channel blocking agent (34, 35). Thus, studies of bind-
ing of these cations to other NMDA-R agonists and antagonists
are especially relevant. Con-G binds tightly to the NMDA-R (5).
Such high avidity would not be expected of a small and loosely
structured peptide, such as con-G, because its conformational
equilibrium mixture likely includes many inactive conformer
species. The elimination of a significant population of inactive
conformations, through metal-dependent a-helical induction,
4 It should be noted that the detection of two metal binding sites in
con-G as determined by isothermal calorimetry under our working
concentrations of peptide (,1 mM) does not rule out the existence of
additional site(s) too weak to be detected by this method. As discussed
previously (34) the product of the binding constant and the concentra-
tion of the macromolecular component of the titration must lie between
1 and 1000 in order to obtain an isotherm from which a precise value for
the binding constant can be extracted. As such, a weak binding site
characterized by a Kd of approximately 5 mM (Ka 5 200 M
21) would
necessitate peptide concentrations of greater than 5 mM for the gener-
ation of useful isotherms. Such experiments not only are limited by the
availability of peptidic material but also may be hindered by metal-
induced peptide aggregation at these very high concentrations.
5 M. Prorok and F. J. Castellino, unpublished data.
FIG. 9. Circular dichroism titra-
tions of con-G with Mg21. The effects of
titration with Mg21 on the a-helical con-
tents of apo-con-G (f) and con-G-Gla3Ala
(E) were determined by titration with
metal ion. The values of the molar ellip-
ticities at 222 nm are plotted against the
total Mg21 concentrations. The buffer was
10 mM Na-Mes, 100 mM NaCl, pH 6.5, at
25 °C.
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might be expected to facilitate tighter receptor binding. This is
especially relevant when the conformational stabilizing ele-
ments are critical components of the physiological milieu and
are as important to the function of the NMDA-R as are Ca21
and Mg21. For example, it has been shown that 30-ml intrace-
rebral injections of a 150 mM con-G solution into pre-2-week-old
mice are sufficient to induce a deep and prolonged sleep-like
state in these subjects (6). Assuming a peptide dilution factor of
10-fold arising from a brain volume of 300–500 ml6 and a
cerebrospinal fluid concentration of Mg21 of 1.5 mM, this would
lead to essentially 100% occupancy of the tight Mg21 site (Kd 5
20 mM) of con-G and about 80% occupancy of the weaker site (Kd
5 285 mM). Under these bioassay conditions, con-G clearly
predominates in its metal-bound, highly a-helical conforma-
tion, strongly suggesting the primacy of this structured form in
mediating the observed physiological effects.
In a previous study, the NMR solution structure of apo-
con-T was solved (11). The data were consistent with a struc-
ture composed of a a-helix spanning the entire length of the
peptide with well-defined backbone and side-chain orienta-
tions, due to the existence of many favorable interactions
optimal for stabilization of the a-helix. Based on the well
folded nature of apo-con-T a-helix, it was further considered
that the a-helical structure would be the bioactive conforma-
tion, because denaturing an a-helix by subsequent receptor
binding would be energetically unfavorable. In the present
study, con-G, a peptide with similar NMDA-R antagonist
properties as con-T, was similarly investigated. The results
demonstrated that apo-con-G is largely in a randomly dis-
persed conformation, whereas the Ca21-loaded and, espe-
cially, the Mg21-loaded forms of this peptide possessed a very
distinct a-helical conformation. In addition, the Ca21- or
Mg21-induced conformations of con-G are both amino- to
carboxyl-terminal end-to-end a-helices. A superimposition of
Ca21/con-T (12) and Mg21/con-G structures shows a large
degree of similarity for the peptide backbone (Fig. 6). That
both peptides with the same biological properties adopt a
very similar structure again suggests that an a-helix may be
the bioactive conformation for both con-G and con-T.
Properties of Con-G Mutants—A number of mutant peptides
have been constructed to attempt to assess the importance of
individual Gla residues in cation binding and cation-dependent
properties of con-G. From the model of Fig. 7, it appears as
though all Gla residues are involved in cation binding, a situ-
ation that contrasts to that of con-T, wherein Gla4 does not
appear to participate in metal ion coordination. The presence of
the centrally located Gla7 in con-G, a residue absent in con-T,
appears to bestow somewhat different metal ion binding prop-
erties on this peptide. Under the conditions employed in our
direct Mg21 binding studies, wild-type con-G harbors two bind-
ing sites, whereas all of the Gla-derived mutants possess only
a single site (Table II). Although it is not necessarily the case
that all of these mutants bind Mg21 in a manner similar to the
parent peptide (they could behave as independent and nonre-
lated peptides in this regard), and this could be reflected in the
intermediate values of the Kd values for the single site in the
Gla4Ala and Gla10Ala mutants (Table II), the situation that
Mg21 binding of the variant peptides can be modeled solely by
considerations of cation binding to wild-type con-G will be
assumed to be true simply for purposes of this discussion. If it
is the case, then, from Table II, it appears that Gla10 and Gla14
coordinate the tight Mg21 site, whereas Gla3, Gla4, and Gla7
appear to make up the weaker cation site. This conclusion is
fortified by the NMR data of Table S1a–c, wherein the chemical
shifts of the gCH protons of these Gla residues are significantly
shifted in the presence of Mg21. The only uncertainty concerns
Gla4, which does not undergo a pronounced chemical shift of its
gCH proton upon addition of Mg21. Thus, its significant effect
on Mg21 binding (Table II) may reside in a deleterious effect of
its mutation on the conformation of the peptide at its amino-
terminal region. Specifically, the first four aNH groups are not
hydrogen bonded, and Gla4 may be required for stabilization of
the a-helix in this location by capping amino-terminal back-
bone amides. Thus, replacement of this residue by Ala might
disrupt the a-helix or prevent its formation at the amino ter-
minus of the peptide and in this way affect metal binding
indirectly. Further studies with additional peptide variants are
required to arrive at more firm conclusions regarding whether
the role of Gla4 in cation binding is direct or indirect.
Each of the Gla residues of con-G appears to be involved in
the ability of this peptide to assume its full cation-dependent
a-helical conformation (Table II). However, in each case, the
C50 for Mg
21, which characterizes the Mg21 dependence of this
conformational change, reflects the Kd for Mg
21 determined
from direct binding studies. This shows that the tight and weak
metal binding sites all contribute to the ability of con-G to
assume the metal-dependent conformation and that both sets
of binding sites, as enforced by the full complement of Gla
residues, need to be occupied for this maximum alteration to
occur.
Conclusions—This study has provided compelling structural
evidence that further supports our original position that con-G
exhibits no conformational preference in the absence of diva-
lent metal ions. In addition, it has served to explain the effects
of Ca21 and Mg21 binding on the peptide structure of con-G.
The lack of sufficient con-G/Ca21 NOE distance constraints to
fully define side-chain orientations appears to be directly re-
lated to its lower metal ion affinity. In contrast, the tighter
binding Mg21 ions allowed a detailed structural analysis to be
performed that was of a resolution sufficiently high to confi-
dently predict metal binding sites. Thus, when comparing the
effects of these two physiologically relevant metals, it is con-
cluded that Mg21, and not Ca21, is likely the major contributor
to the bioactive conformation of con-G.
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23. Wüthrich, K. (1986) NMR of Proteins and Nucleic Acids, John Wiley & Sons,
Inc., New York
24. Némethy, G., Gibson., K. D., Palmer, K. A., Yoon, C. N., Paterlini, G., Zagari,
A., Rumsey, S., and Schereaga, H. A. (1992) J. Phys. Chem. 96, 6472–6484
25. Ni, F., Konishi, Y., Bullock, L. D., Rivetna, M. N., and Scheraga, H. (1989)
Biochemistry 28, 3106–3119
26. Ni, F., Zhu, Y. i., and Scheraga, H. A. (1995) J. Mol. Biol. 252, 656–671
27. Vásquez, M., and Scheraga, H. A. (1988) J. Biomol. Struct. Dyn. 5, 757–784
28. Li, L., Darden, T. A., Freedman, S. J., Furie, B. C., Furie, B., Baleja, J. D.,
Smith, H., Hiskey, R. G., and Pedersen, L. G. (1997) Biochemistry 36,
2132–2138
29. Pearlman, D. A., Case, D. A., Caldwell, J. W., Ross, W. S., Cheatham, T. E. I.,
Ferguson, D. M., Seibel, G. L., Singh, U. C., Weiner, P. K., and Kollman,
P. A. (1995) Amber, Version 4.1, University of California, San Francisco
30. Essmann, U., Perera, L., Berkowitz, M. L., Darden, T., Lee, H., and Pedersen,
L. G. (1995) J. Chem. Phys. 103, 8577–8593
31. Chen, Y.-H., Yang, J. T., and Martinez, H. M. (1972) Biochemistry 11,
4120–4131
32. Wishart, D. S., Sykes, B. D., and Richards, F. M. (1992) Biochemistry 31,
1647–1651
33. Blandl, T., Zajicek, Y., and Castellino, F. J. (1997) Biochem. J. 328, 777–783
34. Wiseman, T., Williston, S., Brandts, J. F., and Lin, L.-N. (1989) Anal. Biochem.
179, 131–137
35. Mayer, M. L., Westbrook, G. L., and Guthrie, P. B. (1984) Nature 309, 261–263
Solution Structure and Cation Binding of Conantokin-G16258
